Merit Medical Systems, Inc. (MMSI)
| Market Cap | 3.07B |
| Revenue (ttm) | 963.79M |
| Net Income (ttm) | -29.43M |
| Shares Out | 55.51M |
| EPS (ttm) | -0.18 |
| PE Ratio | n/a |
| Forward PE | 31.35 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $55.72 |
| Previous Close | $54.85 |
| Change ($) | 0.87 |
| Change (%) | 1.59% |
| Day's Open | 55.34 |
| Day's Range | 54.29 - 56.15 |
| Day's Volume | 409,205 |
| 52-Week Range | 25.18 - 61.23 |
Merit Medical (MMSI) benefits from growth in revenues at the Cardiovascular segment in Q4.
Merit Medical (MMSI) delivered earnings and revenue surprises of 25.58% and 3.05%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Merit Medical Systems (NASDAQ:MMSI) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 35.00% year over year to $...
* Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A reconcil...
On Wednesday, February 24, Merit Medical Systems (NASDAQ:MMSI) will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SOUTH JORDAN, Utah, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, ...
SOUTH JORDAN, Utah, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interven...
Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.
SOUTH JORDAN, Utah, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interven...
Merit Medical Systems (MMSI) has been struggling lately, but the selling pressure may be coming to an end soon.
Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.
Investor confidence is high on Merit Medical (MMSI) stock, courtesy of its solid prospects.
Top Ranked Growth Stocks to Buy for November 30th
Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
SOUTH JORDAN, Utah, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interven...
Despite a solid 2x rise since the March 23 lows of this year, at the current price of around $50 per share we believe Merit Medical Systems stock, a company that manufactures disposable medica...
Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.
Does Merit Medical (MMSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Top Ranked Momentum Stocks to Buy for November 2nd
Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Merit Medical (MMSI) reported growth in revenues at Cardiovascular segment in the third quarter.
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q3 2020 Results - Earnings Call Transcript
Merit Medical (MMSI) delivered earnings and revenue surprises of 121.05% and 11.38%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...
* Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A reconcil...
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SOUTH JORDAN, Utah, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, ...
“Foundations for Growth” Investor Call will Introduce the Company’s Multi-Year Financial Targets for Growth and Improved Profitability “Foundations for Growth” Investor Call will Introduce the...
Backed by projections of robust earnings growth rates, there are a few MedTech stocks which are ideal for long-term bet.
GALWAY, Ireland--(BUSINESS WIRE)-- #cambusmedical--The acquired assets will be absorbed by Cambus Medical, a Freudenberg Medical company and market leading hypotube manufacturer.
SOUTH JORDAN, Utah, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventiona...
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock?
MedTech stocks play a major role in holding the index up and ending the shortest bear run in the history of S&P 500.
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2020 Results - Earnings Call Transcript
Merit Medical (MMSI) reported a drop in revenues at every key operating segment in Q2.
Merit Medical (MMSI) delivered earnings and revenue surprises of 933.33% and 13.01%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
* Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A reconcili...
Merit Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81. The post Merit Medical Systems Scores Relative Strength Rating Up...
Merit Medical Systems (MMSI) had its Relative Strength (RS) Rating upgraded from 70 to 77 Monday -- a welcome improvement, but still below the 80 or higher score you prefer to see.
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SOUTH JORDAN, Utah, July 17, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in card...
Merit Medical (MMSI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
SOUTH JORDAN, Utah, July 15, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional...
Investor confidence is high on Merit Medical (MMSI) stock, thanks to solid prospects.
PHILADELPHIA, June 6, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (Nasdaq: MMSI) on behalf of the Com...
Starboard Value, a top-tier activist investor firm, amassed a 9% stake in Merit Medical Systems, Inc. (NASDAQ: MMSI), a manufacturer of disposable medical devices, CNBC reported.
A successful activist is gently pushing for change at Merit Medical Systems.
Nominates Three Medical Device Industry Veterans – Lonny Carpenter, David Floyd and James Hogan – for Election to the Board of Directors
About MMSI
Merit Medical Systems manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, interventional fluid management, pressure monitoring, and cardiac... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date Aug 9, 1990 |
| CEO Fred Lampropoulos | Employees 6,000 |
| Stock Exchange NASDAQ | Ticker Symbol MMSI |
Financial Performance
In 2019, MMSI's revenue was $994.85 million, an increase of 12.70% compared to the previous year's $882.75 million. Earnings were $5.45 million, a decrease of -87.03%.
Analyst Forecasts
According to 9 analysts, the average rating for MMSI stock is "Buy." The 12-month stock price forecast is 64.56, which is an increase of 15.87% from the latest price.